Examples of clinical trials supplied by pharma
April 2021, Genmab
FDA approved tisotumab vedotin for the treatment of patients with recurrent or metastatic cervical cancer with disease progression on or after chemotherapy.
In recurrent and metastatic cervical cancer we have less therapies. Therefore we welcome all possibilities. Although it is FDA approved, hopefully we will hear about EMA approval soon! Read the whole Press Release here.
April 2021, Karyopharm
March 2021, GSK
Niraparib NOVA Clinical Trial Overview
GARNET Trial Overview Infographic
Niraparib PRIMA Trial Infographic
Niraparib MOONSTONE Infographic
Niraparib Ovarian Cancer Clinical Trials Overview
PLS POSTER Dostarlimab GARNET PRO Kristeleit ESMO 2020